Objective: With improved diagnostic imaging techniques, it remains difficult to reduce occult metastatic disease in oral squamous cell carcinoma (SCC) to less than 20%. Therefore, supraomohyoid neck dissection (SOHND) still is a valuable staging procedure in these patients. Methods: Patients with clinically and ultrasonographically staged cN0 SCC of the oral cavity underwent FDG-PET before SOHND. Histologic examination of neck dissection specimens was used as a "gold standard." Results: Twenty-eight consecutive patients were included, representing 30 necks. Occult metastatic disease was found in 30% of SOHND specimens. Average diameter of metastatic deposits was 4.3 mm. Sensitivity, specificity, and accuracy of FDG-PET was 33%, 76%, and 63%, respectively. Conclusions: In patients with cN0 SCC of the oral cavity, FDG-PET does not contribute to the preoperative workup. FDG-PET does not replace SOHND as a staging procedure.
INTRODUCTION
The oral cavity is one of the cancer sites in the head and neck accompanied by a high incidence of occult regional metastasis. Because the presence of cervical lymph node metastasis significantly reduces survival, this important prognostic factor remains an issue for scientific debate. In these discussions, the changing necessity, diagnostic value, and therapeutic role of a selective neck dissection of levels I through III, also called supraomohyoid neck dissection (SOHND), is often addressed. In 1980, Hanley 1 summarizes the opinion at that time about SOHND as a well-recognized, although generally unaccepted form of treatment in patients with oral cavity cancer. He compared SOHND with the standard radical neck dissection in 62 patients with oral cavity tumors and found "similar and no worse results for the SOHND." He felt that less than radical neck dissection required further exploration. Since then, the opinion about SOHND has gradually changed. 2 SOHND has been popularized over the years and has become a generally accepted staging procedure for the clinically negative neck in patients with oral cancer. 3, 4 In cases of limited nodal disease on histopathologic examination, some consider it therapeutic. 5 Several studies have shown that even with improved diagnostic imaging techniques, it still remains difficult to reduce occult metastatic disease in oral cavity cancer to less than in 20% of the patients. 3, 4 The 20% threshold is considered important because elective treatment of the neck remains indicated when the probability of occult neck metastases exceeds 20%. 6 Palpation of the neck, with a sensitivity and specificity of 60% to 80%, is not a very accurate way to search for cervical metastases. Computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US), sentinel lymph node biopsy (SLNB), and ultrasound-guided fine needle aspiration cytology (USgFNAC) have been shown to be superior to palpation, with the latter being the most accurate way of investigation. However, in patients with a clinically negative neck, even USgFNAC is reported to have a sensitivity of no more than 48% to 76%, most likely explained by the limited tumorload. 7, 8 USgFNAC of the sentinel node does not seem to increase sensitivity. 9 With these results in mind, the risk of occult metastatic disease remains between 15% and 25%. 9, 10 Positron emission tomography (PET) with fluorodeoxyglucose (FDG) is increasingly used in preoperative staging of cancer patients. FDG depicts the increased metabolism of malignant cells as compared with normal cells. Reports on the value of FDG-PET in detecting occult metastatic disease have been contradictory with a reported sensitivity ranging from 0% to 100% and specificity from 92% to 100%. [11] [12] [13] The added value of FDG-PET to the clinical and ultrasonographic evaluation of the neck in oral carcinoma has not been properly investigated. We conducted a study to evaluate whether further reduction of occult metastatic disease in oral carcinoma can be achieved by adding FDG-PET scanning to the preoperative workup. With 21% reported occult metastatic disease in oral carcinoma after a negative ultrasonographic investigation in our hospital, 10 this could implicate that a diagnostic SOHND would no longer be indicated.
MATERIALS AND METHODS

Patients
This prospective study was performed at the Radboud University Nijmegen Medical Centre between June 2001 and December 2003. All patients planned for SOHND as part of the treatment for a clinically N0 (cN0) squamous cell carcinoma (SCC) of the oral cavity were included in the study and offered a FDG-PET scan. Before inclusion, all patients were clinically staged N0. A cN0 neck is defined as a neck staged N0 by preoperative palpation by an experienced ear, nose and throat surgeon, oral and maxillofacial surgeon, and radiotherapist and a standard preoperative US performed with USgFNAC on indication. FNAC of enlarged lymph nodes was performed in nodes with a diameter Ͼ0.5 cm. In case of a cN-positive neck, the patient was offered a modified radical neck dissection (MRND) and was excluded from the study. The study was approved by the local medical ethics committee. Informed consent was obtained from all patients. No patient experienced cancer within 5 years before this study and was not previously treated by radiotherapy or chemotherapy.
FDG-PET
A dedicated PET-scanner (ECAT-EXACT; Siemens/CTI, Knoxville, TN) was used for data acquisition. Before FDG injection, patients fasted for at least 6 hours. Intake of sugar-free liquids was permitted. Immediately before the procedure, the patients were hydrated with 500 mL of water. One hour after intravenous injection of 220 to 250 MBq FDG (Mallinckrodt Medical, Petten, The Netherlands) and 20 mg furosemide, emission and transmission images of the head and neck area were acquired (2-3 bed positions, 10 minutes per bed position). The images were corrected for attenuation and reconstructed using the orderedsubsets expectation maximization (OSEM) algorithm. The reconstructed images were displayed in coronal, transverse, and sagittal planes and evaluated by three nuclear medicine physicians.
The mean glucose level just before PET imaging was 5.3 mmol/L; three patients had diabetes mellitus (glucose levels 10.3, 6.8, and 3.4 mmol/L).
For statistical analysis the sensitivity, specificity and accuracy of FDG-PET were calculated.
Surgical Technique and Pathologic Examination
SOHND was performed as described by Medina et al. 2 In case of enlarged or suspicious nodes found during surgery, frozen stage section (FSS) analysis was performed. If positive, the neck dissection was extended to a MRND. The neck dissection specimen was marked anatomically by the surgeon (a senior staff member of the Department of Otorhinolaryngology and Head & Neck Surgery or the Department of Oral and Maxillofacial Surgery) and sent for pathologic examination consisting of node count, evaluation of malignancy in any of the nodes, and extracapsular spread. Standard sectioning and hematoxylin & eosin staining were performed on all lymph nodes. Lymph node metastases were defined as micrometastasis when a metastatic deposit had a largest diameter of less than 4 mm.
RESULTS
Thirty patients (15 male, 15 female; median age 60 years, range, 32-84 years) were enrolled. One FDG-PET scan was unevaluable as a result of significant movement of the (diabetic) patient during imaging. One patient had a SOHND 49 days after FDG-PET and was also excluded. Twenty-eight scans could be evaluated (15 women, 13 men), representing 30 SOHNDs. Site of the primary tumor and T stage are shown in Table I . None of the patients had any sign of metastatic spread based on clinical examination and US of the neck. In eight patients, US was supplemented with USgFNAC, which resulted in negative cytology. Additionally, four patients had a CT of the head and neck, all without suspect nodes. In 26 patients (28 necks), FSS of the neck specimen was performed: 25 (89%) necks were negative and three (11%) were positive. All three necks positive on FSS turned out to be true-positive and one of 25 negative FSS specimens turned falsenegative during further pathologic investigation. In the three necks (10% of necks) with a positive FSS of the SOHND specimen, the SOHND was extended to a MRND. No additional metastatic nodes were found in levels IV and V. A total number of 555 nodes was examined in 28 patients. The total number of nodes found in regions I to III varied from 11 to 38. Nine of 30 necks (30%) contained occult metastases in a total of 16 lymph nodes; no bilateral metastases were found. The average diameter of the metastatic deposit was 4.3 mm (range, 0.5-8.0 mm). Five of the malignant nodes showed signs of extracapsular spread, being a prognostic factor of enhanced metastatic spread. 3 An overview of the patients and their nodes is presented in Table II .
Ultrasound-Guided Fine Needle Aspiration Cytology
Three of eight patients (38%; three of nine punctured necks: 33%) in whom USgFNAC was negative did have lymph node metastases at pathologic examination of the SOHND specimen; in one case, a node in the punctured level was positive; the other two patients had one and two positive nodes in nonpunctured levels. In patients in whom no USgFNAC was performed, six of 21 SOHND specimens proved to be positive for lymph node metastases (29%).
FDG-PET
In one patient (3.6%), the FDG-PET scan showed no sign of the primary tumor because this tumor (tongue) was already removed by a radical excision biopsy in a secondary referral center. The other 27 primary tumor sites were correctly depicted. This leads to a sensitivity of 100% for visualizing the primary tumor. In eight cases (29%), FDG-PET showed ipsilateral hot spots suspect for possible metastases; 20 scans representing 22 necks were negative. Patients were on average surgically treated within 14 days (range, 1-30 days; median, 12 days) after receiving their PET scan. Twentyeight patients underwent 30 neck dissections (two bilateral as a result of a floor of the mouth tumor crossing the midline).
FDG-PET correctly recognized three of nine (33%) afterward pathologically proven positive necks; these positive nodes were found in the correctly depicted level, although one patient had seven positive nodes divided among levels I and II. His PET scan only showed three positive spots in level II. In five patients, FDG-PET showed a suspect node, which was not confirmed by pathologic examination; in one of these cases, USgFNAC was performed 3 weeks before FDG-PET. FDG-PET also failed to show any positive nodes in six patients while pathologically present, leading to a sensitivity and specificity of 33% and 76%, respectively, for 30 necks. Accuracy reached 63% for FDG-PET. If SOHND would only be performed when FDG-PET was positive for lymph nodes, the number of SOHNDs would have been reduced by 73% (from 30 -8). However, this algorithm would result in six of 30 necks with unrecognized occult metastases (20%).
DISCUSSION
Supraomohyoid neck dissection has shown to be a valid staging procedure in cN0 oral SCC. 3 It provides valuable clinical information on the status of the neck at the expense of minimal morbidity. 31 CT, MRI, and US lack sensitivity and specificity for diagnosing occult metastatic disease because micrometastases can occur in the absence of morphologic changes in lymph nodes, whereas these changes can be both reactive and metastatic. That is the main reason why USgFNAC is considered to be superior to these imaging modalities, especially when normal-sized and thus nonsuspicious nodes in the first echelons are punctured. Because the majority of patients in this study did not receive FNAC, this might explain why the 30% of necks with occult metastatic nodes in this study was higher than the initially reported 21% 10 from our institute. All metastases in the SOHND specimens were located in the first echelons. Because the metastatic parts of the affected nodes were very small, morphologic changes were unlikely to appear in the majority. Furthermore, CT scanning of the head and neck is no standard preoperative staging technique in patients with a cN0 neck in oral SCC according to the national Dutch guideline on diagnosis and treatment of oral and oropharyngeal cancer.
Several studies have shown that it is possible to reduce occult metastatic disease in oral SCC to approximately 20%. 5, 10 Because a 20% false-negative rate is considered to be the limit for a wait-and-see policy versus elective treatment of the neck, 6 clinicians are expected to be divided into two groups advocating either one of these treatment strategies. However, clinical studies were often retrospective or lacked sufficient power and follow-up time to show a survival benefit for any particular option. [33] [34] [35] [36] [37] [38] Many surgeons feel that the morbidity of a SOHND is acceptably low and outweighs the risk of being confronted with advanced neck disease after a wait-and-see or wait and scan policy. 14 Nevertheless, if a diagnostic strategy would further reduce the rate of occult metastasis, SOHND could be abandoned. Recent studies have mainly focused on sentinel node biopsy and FDG-PET scanning of the neck.
Sentinel lymph node biopsy (SLNB) in cutaneous malignant melanoma has been demonstrated to be a minimally invasive technique with a high degree of accuracy in detecting occult metastatic disease. Morton et al. 40 reported a false-negative rate of SLNB in cN0 cutaneous malignant melanoma of the head and neck area of less than 1%. SLNB might possibly identify those patients who harbor occult metastatic disease in cN0 oral SCC. Ross et al. 15 describe the preliminary results of a multicenter trial in patients with T1 to 2N0 oral cavity/oropharynx carcinoma. In 93% of 134 cases, a sentinel node could be identified. In 55 cases, SLNB was combined with an elective neck dissection. Occult metastatic disease was present in 34%. Sensitivity of this technique was reported to be 93% in all oral SCC. In floor of the mouth SCC only, however, identification of the SLN was possible in 86% (n ϭ 43) and sensitivity reached 80%. Besides selection of patients for (additional) neck surgery, histopathologic evaluation of the sentinel node might limit cost and time-consuming pathologic evaluation by performing step serial sectioning and immunohistochemistry of the sentinel nodes that are most suspected to harbor metastases. However, skip metastases might prove to be a problem. 16 Difficulties identifying level I sentinel lymph nodes in oral SCC have been reported. 15 In our series, 31% of the metastatic nodes were located in level I. Thus, questions about whether SLNB offers a significant advantage over SOHND still remain. Unresolved issues regarding this technique are the feasibility of and efficacy in multiple-level sentinel nodes and the cost-effectiveness.
Furthermore, underestimation of occult metastatic disease with standard sectioning and hematoxylin & eosin staining is likely to be present in approximately 5% to 8%. 17, 18 It is unclear if these micrometastases need more than a SOHND or if SOHND can be considered adequate treatment in these cases. Potential overtreatment of such limited disease with a MRND needs to be subject of clinical studies as stated by Pitman et al. in a review on SLNB in head and neck cancer. 19 Nieuwenhuis et al. 9 investigated the role of USgFNAC of the sentinel node in cT1 to 2N0 oral/oropharyngeal carcinoma. Although the sentinel node could be identified and aspirated in 38 of 39 patients, it did not decrease the false-negative rate compared with USgFNAC alone. The additional value of sentinel node cytology was thus questioned. Considerable attention has been paid to FDG-PET in the evaluation of the N0 neck in head and neck cancer. In our study, we have included only patients without evidence of metastatic neck disease in preoperative evaluation consisting of at least palpation and US and who were thus scheduled for surgical treatment, including a SOHND. Sensitivity in this selected patient group is insufficient to refrain from SOHND on the basis of FDG-PET.
Initial reports about FDG-PET for lymph node staging of the neck in head and neck SCC were very optimistic with sensitivity and specificity values between 72% to 91% and 88% to 98%, respectively. 26,47 Stuckensen et al. 24 performed a prospective study in 106 patients with oral SCC and compared FDG-PET, US, CT, and MRI with histologic results of the neck dissection specimen. Only 48 of 106 patients included in the study were staged cN0. FDG-PET had a sensitivity of 70% and a specificity of 82%. There was a correlation with the size of the lymph node metastases. Most of the metastases larger than 12 mm were detected but less than half of those smaller than 6 mm. Therefore, it is likely that sensitivity and specificity in the cN0 group were worse than those reported for the complete group.
In FDG-PET studies specifically addressing patients with oral cavity or oropharyngeal cancer with a cN0 neck, huge variations in sensitivity (from 0 -100%) and specificity (92-100%) are reported. [11] [12] [13] 20 Brouwer et al. 11 showed that in the studies using routine histopathologic workup, 22 a much higher sensitivity (67-100%) for the detection of occult lymph node metastases was found in comparison to the studies in which step sectioning and immunohistochemistry as part of the sentinel node procedure was performed. In the latter studies, a sensitivity of only 0% to 40% was found. 20 They point out that the histopathologic method used seems to be the most important factor for the differences in sensitivity. However, we feel that patient selection and differences in inclusion criteria are other major reasons for these differences. In the "less sensitive studies," only patients were included who were clinically as well as ultrasonographically N0, and in the "sensitive studies," patients were included who had a clinically negative neck but often had radiologic evidence of metastatic disease. [12] [13] [14] 20 If the results of the studies in Table III are combined, while excluding patients with radiologic evidence of metastases, overall sensitivity drops from 38% to 25% (84 patients, 92 necks). This is in line of the diagnostic yield of FDG-PET in our study of patients with lymph node metastases all smaller than 8 mm.
CONCLUSION
FDG-PET does not lower the false-negative rate of occult lymph node metastases in patients with an oral SCC and a clinically and US-negative neck below the clinically required 20% of patients. Therefore, FDG-PET has no added value in the preoperative workup. FDG-PET alone or in combination with US (ϮFNAC) cannot replace SOHND as a staging procedure.
